Technetium-99m-tetrofosmin single-photon emission computed tomography at rest is practical for routine assessment of viability in patients with ischemic cardiomyopathy. However, underestimation of viability may occur compared with 18F-fluorodeoxyglucose single-photon emission computed tomography, especially in the inferoposterior and septal regions.,
The American Journal of Cardiology
Department of Cardiology

Schinkel, A., Poldermans, D., Bax, J., Biagini, E., Elhendy, A., van Domburg, R., … Simoons, M. (2005). Myocardial technetium-99m-tetrofosmin single-photon emission computed tomography compared with 18F-fluorodeoxyglucose imaging to assess myocardial viability. The American Journal of Cardiology, 95(10), 1223–1225. doi:10.1016/j.amjcard.2005.01.050